GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline Read more
Novartis Scemblix FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile Read more
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases Read more
Iterum Therapeutics Receives FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections Read more
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer’s Disease and Neuroscience Pipeline Read more
Astellas Provides Update on Marketing Authorization Application for Avacincaptad Pegol (ACP) in the European Union Read more